{
    "2019-08-14": [
        [
            {
                "time": "2019-08-14",
                "original_text": "Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study",
                "features": {
                    "keywords": [
                        "Taltz",
                        "Tremfya",
                        "Psoriasis",
                        "study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-14",
                "original_text": "Health Care Sector Update for 08/14/2019: TLRY, ZLAB, NVCR, MNK, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "TLRY",
                        "ZLAB",
                        "NVCR",
                        "MNK",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-14",
                "original_text": "JNJ Stock Is a Way Better Investment Than Bonds or CDs",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Stock",
                        "Investment",
                        "Bonds",
                        "CDs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "dividend stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}